Effects of fullerenol nanoparticles on kidney tissue in sevoflurane‑treated rats

Bratisl Lek Listy. 2020;121(2):117-121. doi: 10.4149/BLL_2020_015.

Abstract

Aim: The aim of this study is to demonstrate whether fullerenol C60 protects renal injury in sevoflurane‑administered rats.

Method: Rats (n: 24) were randomly divided into four groups: Control (Group C), Fullerenol C60 (Group F), Sevoflurane (Group S), Fullerenol C60-Sevoflurane (Group FS). Thirty minutes before the procedure, Fullerenol C60, 100 mg/kg, was administered intraperitoneally. Sevoflurane (2.3 %) was applied for 3 hours to rats in S and FS groups. Biochemical and histopathological parameters were analyzed in renal tissue samples. Kruskal-Wallis and Mann-Whitney U tests were used in statistical analyzes.

Results: Malondialdehyde (MDA) level and catalase (CAT) enzyme activity in Group S were significantly higher than that in all other groups. Paraoxanase (PON) enzyme activity in Group S was significantly lower than in Groups C and FS. The histopathological examination showed that vascular vacuolization and hypertrophy (VVH) and lymphocyte infiltration (LI) were significantly higher in the Group S compared to the Group C.

Conclusion: Renal histopathology revealed that the administration of Fullerenol C60 prior to sevoflurane inhalation reduced oxidative stress and partially corrected the damage caused by anesthesia. We concluded that Fullerenol C60 has a renal protective effect in rats when administered before sevoflurane anesthesia (Tab. 2, Fig. 4, Ref. 40).

Keywords: MDA PON-1.; fullerenol C60; renal injury; sevoflurane.

MeSH terms

  • Animals
  • Fullerenes* / pharmacology
  • Kidney* / drug effects
  • Malondialdehyde
  • Nanoparticles*
  • Oxidative Stress
  • Rats
  • Sevoflurane

Substances

  • Fullerenes
  • fullerenol
  • Sevoflurane
  • Malondialdehyde